· Investment Strategies · 1 source · Updated · Verified
AlphaPai’s $50M Series B: Insurance and Broker Capital Buy Research AI
Hong Kong’s AlphaPai raised $50M Series B on September 15, 2026 — its third round in a year — with China Insurance Investment and GF Securities’ PE arm joining Qiming and others. Company: 120,000+ professional users across 8,000+ institutions.
By Venture Capital Tracker Editorial
AlphaPai (Rabyte Technology) closed a $50 million Series B on September 15, 2026 — its third financing in roughly a year — with China Insurance Investment and GF Xinde (GF Securities’ PE arm) joining Qiming Venture Partners, Ambrum, Next Capital, Trustar, Eastern Bell, and existing holders (PR Newswire Asia).
Financial AI is raising into workflow ownership — not meeting bots — and the syndicate is dominated by industry capital that buys the product category.
Key facts
- Company
- AlphaPai — Hong Kong; AI investment research
- Round
- $50M Series B; 3rd round in ~1 year; valuation n/d
- Strategic anchors
- China Insurance Investment; GF Xinde (GF Securities)
- Other named
- Qiming, Ambrum, Next Capital, Trustar, Eastern Bell + existing
- Advisor
- China Renaissance (exclusive FA)
- Traction (company)
- 120,000+ professional users; 8,000+ institutions
- Product
- AlphaPai assistant; PaiWork workstation (Apr 2026); iRaB benchmark; ORE partner program (40+ institutes)
None of these investors sit in our /fund/ directory — editorial names only.
Who uses the product — and for what job
Users: Professional investors inside banks, brokers, asset managers, and insurance investment teams who live in meetings, filings, models, and knowledge bases.
Job today: Move from high-frequency AI assists (meetings, information processing) into core research production — analysis, institutional knowledge, multi-asset workflows inside PaiWork.
Job next: Deeper insurance and multi-asset coverage, supply-chain collaboration with data/broker partners, and a measured overseas push after proving the China institutional density story.
Why now
- Generic LLM chat lost the “wow” premium; institutions pay for workflow + compliance-shaped research environments.
- Insurance capital and securities PE joining the cap table is distribution and credibility for regulated research use cases.
- Third round in a year implies either rapid product adoption or a hot Asia financial-AI window — diligence which.
Why these funds — portfolio fit
China Insurance Investment is not a tourist check: insurance portfolios span equities, fixed income, and alternatives with long research chains. Owning a stake in the research assistant that might sit inside those chains is strategic co-creation, not only financial IRR.
GF Xinde / Guanggu-linked capital explicitly incubates advisory-ecosystem fintech — AlphaPai sits in the “service provider” layer of that thesis.
Qiming and the other named VCs provide classic venture scaffolding around industrial capital so the round is not only strategic soft money.
Competitive map
| Approach | Tradeoff |
|---|---|
| Horizontal copilots (ChatGPT Enterprise, etc.) | Flexible; weak finance-native data/eval loops |
| Incumbent terminal add-ons | Distribution; slower agent/workstation UX |
| Meeting-only fintech AI | Clear wedge; stalls before research core |
| AlphaPai PaiWork + ecosystem (iRaB/ORE) | Workflow depth; China-market concentration risk |
What is not proven
- Valuation, prior round sizes, and revenue / ARR.
- Independent verification of 120k users / 8k institutions and “tens of times” token growth claims.
- Overseas traction beyond stated ambition.
Practical takeaway
- Founders (fintech AI): Industrial capital that uses your category can outrank logo VCs on Series B — if you already sit in production workflows.
- Investors: Diligence user quality (licensed PMs vs free seats) and whether insurance/broker shareholders create pull-through or channel conflict.
- Allocators / researchers: Relevant if you need a China-native research workstation story; treat global claims as forward-looking.
Follow Venture Capital Tracker on Google
Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
